Literature DB >> 23436818

Choosing wisely: the American College of Rheumatology's Top 5 list of things physicians and patients should question.

Jinoos Yazdany1, Gabriela Schmajuk, Mark Robbins, David Daikh, Ashley Beall, Edward Yelin, Jennifer Barton, Adam Carlson, Mary Margaretten, Joann Zell, Lianne S Gensler, Victoria Kelly, Kenneth Saag, Charles King.   

Abstract

OBJECTIVE: We sought to develop a list of 5 tests, treatments, or services commonly used in rheumatology practice whose necessity or value should be questioned and discussed by physicians and patients.
METHODS: We used a multistage process combining consensus methodology and literature reviews to arrive at the American College of Rheumatology's (ACR) Top 5 list. Rheumatologists from diverse practice settings generated items using the Delphi method. Items with high content agreement and perceived high prevalence advanced to a survey of ACR members, who comprise >90% of the US rheumatology workforce. To increase the response rate, a nested random sample of 390 rheumatologists received more intensive survey followup. The samples were combined and weighting procedures were applied to ensure generalizability. Items with high ratings underwent literature review. Final items were then selected and formulated by the task force.
RESULTS: One hundred five unique items were proposed and narrowed down to 22 items during the Delphi rounds. A total of 1,052 rheumatologists (17% of those contacted) participated in the member-wide survey, whereas 33% of those in the nested random sample participated; respondent characteristics were similar in both samples. Based on survey results and available scientific evidence, 5 items (relating to antinuclear antibodies, Lyme disease, magnetic resonance imaging, bone absorptiometry, and biologic therapy for rheumatoid arthritis) were selected for inclusion.
CONCLUSION: The ACR Top 5 list is intended to promote discussions between physicians and patients about health care practices in rheumatology whose use should be questioned and to assist rheumatologists in providing high-value care.
Copyright © 2013 by the American College of Rheumatology.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23436818      PMCID: PMC4106486          DOI: 10.1002/acr.21930

Source DB:  PubMed          Journal:  Arthritis Care Res (Hoboken)        ISSN: 2151-464X            Impact factor:   4.794


  52 in total

1.  Antibodies to extractable nuclear antigens in antinuclear antibody-negative samples.

Authors:  Xavier Bossuyt; Ariane Luyckx
Journal:  Clin Chem       Date:  2005-12       Impact factor: 8.327

2.  Relationship between changes in BMD and nonvertebral fracture incidence associated with risedronate: reduction in risk of nonvertebral fracture is not related to change in BMD.

Authors:  Nelson B Watts; Piet Geusens; Ian P Barton; Dieter Felsenberg
Journal:  J Bone Miner Res       Date:  2005-08-08       Impact factor: 6.741

3.  Guidelines for laboratory evaluation in the diagnosis of Lyme disease. American College of Physicians.

Authors: 
Journal:  Ann Intern Med       Date:  1997-12-15       Impact factor: 25.391

Review 4.  Diagnosis and treatment of Lyme arthritis.

Authors:  A C Steere
Journal:  Med Clin North Am       Date:  1997-01       Impact factor: 5.456

5.  The consequences of overdiagnosis and overtreatment of Lyme disease: an observational study.

Authors:  M C Reid; R T Schoen; J Evans; J C Rosenberg; R I Horwitz
Journal:  Ann Intern Med       Date:  1998-03-01       Impact factor: 25.391

6.  Antinuclear antibody testing. A study of clinical utility.

Authors:  C A Slater; R B Davis; R H Shmerling
Journal:  Arch Intern Med       Date:  1996-07-08

7.  Tick bites and Lyme disease in an endemic setting: problematic use of serologic testing and prophylactic antibiotic therapy.

Authors:  A D Fix; G T Strickland; J Grant
Journal:  JAMA       Date:  1998-01-21       Impact factor: 56.272

8.  Appropriateness of Lyme disease serologic testing.

Authors:  Alan H Ramsey; Edward A Belongia; Po-Huang Chyou; Jeffrey P Davis
Journal:  Ann Fam Med       Date:  2004 Jul-Aug       Impact factor: 5.166

9.  The use of serologic tests for Lyme disease in a prepaid health plan in California.

Authors:  C Ley; C Le; E M Olshen; A L Reingold
Journal:  JAMA       Date:  1994-02-09       Impact factor: 56.272

10.  Methods of choice for diagnostic antinuclear antibody (ANA) screening: benefit of adding antigen-specific assays to immunofluorescence microscopy.

Authors:  Charlotte Dahle; Thomas Skogh; A K Aberg; A Jalal; P Olcén
Journal:  J Autoimmun       Date:  2004-05       Impact factor: 7.094

View more
  26 in total

1.  Variations in Radiographic Procedure Use for Medicare Patients With Rheumatoid Arthritis.

Authors:  Gabriela Schmajuk; Chris Tonner; Laura Trupin; Jinoos Yazdany
Journal:  Arthritis Care Res (Hoboken)       Date:  2017-04-10       Impact factor: 4.794

2.  Incidence and Predictors of Repeat Bone Mineral Densitometry: A Longitudinal Cohort Study.

Authors:  Emily C White VanGompel; Peter Franks; John A Robbins; Joshua J Fenton
Journal:  J Gen Intern Med       Date:  2017-06-20       Impact factor: 5.128

3.  Evaluation of the Canadian Rheumatology Association Choosing Wisely recommendation concerning anti-nuclear antibody (ANA) testing.

Authors:  Robert Ferrari
Journal:  Clin Rheumatol       Date:  2015-06-02       Impact factor: 2.980

4.  Clinical guidelines: can wise choices solve the health-care crisis?

Authors:  Maarten Boers
Journal:  Nat Rev Rheumatol       Date:  2013-05-07       Impact factor: 20.543

Review 5.  Osteoporosis Pathophysiology, Epidemiology, and Screening in Rheumatoid Arthritis.

Authors:  Giovanni Adami; Kenneth G Saag
Journal:  Curr Rheumatol Rep       Date:  2019-05-23       Impact factor: 4.592

Review 6.  Biomarkers in connective tissue diseases.

Authors:  Neelakshi R Jog; Judith A James
Journal:  J Allergy Clin Immunol       Date:  2017-12       Impact factor: 10.793

Review 7.  Outcome assessments in rheumatoid arthritis.

Authors:  Katarzyna Gilek-Seibert; Kara Prescott; Salahuddin Kazi
Journal:  Curr Rheumatol Rep       Date:  2013-11       Impact factor: 4.592

8.  Indications for and clinical procedures resulting from magnetic resonance imaging of the knee in older patients: Are we choosing wisely?

Authors:  Marc-Etienne Parent; François Vézina; Nathalie Carrier; Ariel Masetto
Journal:  Can Fam Physician       Date:  2018-03       Impact factor: 3.275

Review 9.  Review: unraveling Lyme disease.

Authors:  Linda K Bockenstedt; Gary P Wormser
Journal:  Arthritis Rheumatol       Date:  2014-09       Impact factor: 10.995

10.  Frequency of repeat antinuclear antibody testing in Ontario: a population-based descriptive study.

Authors:  Shirley Lake; Zhan Yao; Natasha Gakhal; Amanda Steiman; Gillian Hawker; Jessica Widdifield
Journal:  CMAJ Open       Date:  2020-03-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.